Yahoo
OTC Markets OTCPK - Delayed Quote USD

Biostar Pharmaceuticals, Inc. (BSPM)

0.0001 0.0000 (0.00%)
At close: October 29 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for BSPM
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 150
  • Avg. Volume 61
  • Market Cap (intraday) 263
  • Beta (5Y Monthly) -4,441.38
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

www.biostarpharmaceuticals.com

200

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BSPM
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

BSPM
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

BSPM
0.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

BSPM
99.67%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY10
Revenue 28.28M
Earnings 6.11M
Profit Margin 21.59%

Q4

FY10

0
5M
10M
15M
20M
25M
21.6%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    294.01%

  • Return on Assets (ttm)

    4.25%

  • Return on Equity (ttm)

    2.66%

  • Revenue (ttm)

    317.79k

  • Net Income Avi to Common (ttm)

    934.35k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    364.97k

  • Total Debt/Equity (mrq)

    6.71%

  • Levered Free Cash Flow (ttm)

    7.47M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: